J. Mulshine

R. V. van Klaveren, C. Berg, F. Hirsch, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Molecular Biomarkers Workshop: a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk Populations

F. Hirsch, J. Mulshine, T. Sutedja, 2001 .

Dipyridamole mediated enhanced antiproliferative activity of 10‐ethyl‐10‐deazaaminopterin (10‐EDAM) against human lung cancer cell lines

B. Kramer, A. Gazdar, J. Mulshine, 1996, Journal of cellular biochemistry. Supplement.

In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung.

S. Larson, J. Mulshine, I. Avis, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging.

J. Weinstein, S. Larson, J. Mulshine, 1987, Cancer research.

Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.

J. Minna, A. Gazdar, J. Mulshine, 1984, Cancer research.

Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancer a, b

S. Larson, J. Minna, J. Mulshine, 1988, Annals of the New York Academy of Sciences.

Peptide amidating activity in human bronchoalveolar lavage fluid.

M. Tockman, J. Mulshine, K. Kelly, 1996, Lung cancer.

Rational targets for the early detection of lung cancer.

M. Tockman, J. Mulshine, M. Birrer, 1992, Journal of the National Cancer Institute. Monographs.

Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.

J. Mulshine, K. Kelly, R. Modali, 1996, Analytical Biochemistry.

Prospective trial evaluating immunocytochemical‐based sputum techniques for early lung cancer detection: Assays for promotion factors in the bronchial lavage

M. Tockman, S. Piantadosi, J. Mulshine, 1993, Journal of cellular biochemistry. Supplement.

Lung cancer: rational strategies for early detection and intervention.

J. Mulshine, Y. Nakanishi, F. Cuttitta, 1991, Oncology.

Glycolipid antigen expression in human lung cancer.

J. Minna, J. Mulshine, C. Civin, 1986, Cancer research.

Immunohistochemical localization of the immunodominant differentiation antigen lacto-N-fucopentaose III in normal adult and fetal tissues.

J. Minna, J. Mulshine, S. Rosen, 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop.

J. Mulshine, B. Johnson, J. Battey, 1995, Lung cancer.

Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FunLc6Cer).

J. Mulshine, S. Hakomori, S. Jensen, 1989, Archives of biochemistry and biophysics.

Antigen Retrieval Improves hnRNP A2/B1 Immunohistochemical Localization in Premalignant Lesions of the Lung

T. Zhukov, M. Tockman, J. Mulshine, 1998 .

Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody.

A. Gazdar, J. Mulshine, P. Bunn, 1986, The New England journal of medicine.

Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma.

J. Weinstein, E. Sausville, J. Herdt, 1991, Cancer research.

The National Institutes of Health Experience with Radiolabeled Monoclonal Antibodies: Lymphoma, Melanoma, and Colon Cancer

S. Larson, J. Mulshine, J. Schlom, 1988 .

Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma.

J. Mulshine, P. Bunn, K. Foon, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications.

J. Battey, E. Sausville, J. Minna, 1988, Important advances in oncology.

The use of volumetric CT as an imaging biomarker in lung cancer.

Andrew J Buckler, Binsheng Zhao, Ronald Gottlieb, 2010, Academic radiology.

Early lung cancer detection: approaching the 'tipping point'?

J. Mulshine, 2006, Oncology.

Chapter 19 Some considerations for the therapeutic use of monoclonal antibodies in lung cancer

J. Mulshine, F. Cuttitta, P. Kasprzyk, 1988 .

Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo 1

T. Moody, J. Staley, J. Mulshine, 2006 .

Treatment of non-small-cell lung cancer.

J. Mulshine, E. Glatstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consideration of the Chemistry of Solid‐Phase Matrix Interactions Leads to Improved Quantitation of Neuropeptides a, b

J. Mulshine, I. Avis, Y. Nakanishi, 1988, Annals of the New York Academy of Sciences.

Immunolymphoscintigraphyin Patients with Lymphoma After SubcutaneousInjection of Indium-111-LabeledT 101 Monoclonal Antibody

J. Weinstein, S. Larson, J. Mulshine, 1987 .

Monoclonal antibodies and immobilized antibodies

C. A. White, R. Krauss, M. Melamed, 1987 .

Monoclonal antibody αIR‐3 inhibits non‐small cell lung cancer growth in vitro and in vivo

T. Moody, J. Mulshine, F. Cuttitta, 1996 .

Biochemical characterization of peptide alpha-amidation enzyme activities of human neuroendocrine lung cancer cell lines.

R. Mains, J. Mulshine, B. Eipper, 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line.

E. Sausville, R. Jensen, J. Mulshine, 1988, Biochemical and biophysical research communications.

Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation.

J. Mulshine, I. Avis, Y. Nakanishi, 1988, Analytical biochemistry.

Autocrine growth factors in human small cell lung cancer.

J. Minna, T. Moody, J. Mulshine, 1985, Cancer surveys.

Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.

J. Mulshine, M. Miller, A. Treston, 1999, Lung cancer.

A quantitative method for estimating individual lung cancer risk.

Ricardo S. Avila, Kenneth Jansen, Giulia Veronesi, 2010, Academic radiology.

Pharmacokinetics of In-111 T101 (anti-CD5) monoclonal antibody in patients with cutaneous T-cell lymphoma

S. Larson, J. Mulshine, P. Bunn, 1993 .

Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.

J. Minna, A. Gazdar, J. Mulshine, 1986, Cancer research.

Lack of in Vitro Synergy between Etoposide and cw-Diammine-dichloroplatinum(II)1

S. Steinberg, A. Gazdar, J. Mulshine, 2006 .

Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin

J. Minna, A. Gazdar, H. Pass, 1993 .

Five‐lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions

T. Moody, J. Mulshine, Yung-Hyun Choi, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Effect of gastrin‐releasing peptide on the pancreatic tumor cell line (capan)

J. Mulshine, I. Avis, M. Jett, 1993, Molecular carcinogenesis.

Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.

J. Minna, J. Mulshine, P. Bunn, 1987, Cancer research.

Glycolipid Antigen Expression in Human Lung Cancer1

J. Minna, J. Mulshine, C. Civin, 2006 .

A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone.

J. Siegfried, J. Mulshine, F. Cuttitta, 1992, Proceedings of the National Academy of Sciences of the United States of America.

BRONCHIAL EPITHELIAL CHANGES IN THE EARLY DETECTION OF CANCER : APPLICATION OF MONOCLONAL ANTIBODIES IN THE MANAGEMENT OF LUNG CANCER

J. Mulshine, 2014 .

Immunohistochemical Localization of the Immunodominant Differentiation Antigen Lacto-N-Fucopentaose III in Normal Adult and Fetal Tissues Utilizing Monoclonal Antibodies

J. Minna, J. Mulshine, J. Minna, 1985 .

Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.

G. Giaccone, A. Gazdar, J. Mulshine, 1992, Journal of the National Cancer Institute. Monographs.

A Phase II Trial of Carboplatin (CBDCA) in Small‐Cell and Non‐Small‐Cell Lung Cancer with Correlation to In Vitro Analysis of Cytotoxicity

E. Dmitrovsky, A. Gazdar, J. Mulshine, 1990, American journal of clinical oncology.

Alpha-amidation of peptide hormones in lung cancer.

J. Siegfried, J. Mulshine, I. Avis, 1991, Cancer cells.

Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?

S. Steinberg, A. Gazdar, J. Mulshine, 1988, Experimental cell biology.

BRONCHIAL EPITHELIAL CHANGES IN THE EARLY DETECTION OF LUNG CANCER : APPLICATION OF MONOCLONAL ANTIBODIES IN THE MANAGEMENT OF LUNG CANCER(Special Issue for 13th Annual Congress of the Japan Society for Bronchology)

J. Mulshine, 1990 .

INTEGRATION OF QUANTITATIVE IMAGING INTO LUNG CANCER: KEYNOTE ADDRESS: BRINGING PRECISION QUANTITATIVE IMAGING TO MANAGE MAJOR CHRONIC DISEASES

Raúl San José Estépar, D. Yankelevitz, J. Mulshine, 2015 .

NCI‐navy medical oncology branch cell line data base

J. Minna, A. Gazdar, D. Carbone, 1996, Journal of cellular biochemistry. Supplement.

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.

Anatoly L. Mayburd, James L Mulshine, Anatoly Mayburd, 2005, Cancer research.

Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

R. Shoemaker, A. Gazdar, J. Mulshine, 1993, Investigational New Drugs.

Clinical and Biological Basis of Lung Cancer Prevention.

F. Hirsch, J. Mulshine, N. Martinet, 1999, Respiratory Pharmacology and Pharmacotherapy.

Lung Cancer Chemoprevention

J. Mulshine, L. M. Luca, 2005 .

IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.

E. Dmitrovsky, C. Henschke, F. Hirsch, 2002, Lung cancer.

Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.

S. Steinberg, J. Mulshine, B. Johnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnosis and significance of liver metastases in small cell carcinoma of the lung.

R. Makuch, J. Minna, J. Mulshine, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer: current therapies and new targeted treatments

Walter J Curran, James L Mulshine, W. Curran, 2017, The Lancet.

Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).

S. Steinberg, B. Kramer, A. Gazdar, 1989, Cancer research.

Lung cancer chemoprevention: moving from concept to a reality.

F. Hirsch, J. Mulshine, F. Hirsch, 2003, Lung cancer.

Scientific Advances in Thoracic Oncology 2016.

H. Groen, C. Rudin, R. Rami-Porta, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

New Molecular Strategies for Early Lung Cancer Detection

J. Mulshine, L. Montuenga, 2000, Cancer investigation.

Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer.

J. Battey, J. Minna, A. Gazdar, 1986, Cold Spring Harbor symposia on quantitative biology.

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

S. Steinberg, J. Minna, A. Gazdar, 1992, Oncogene.

Initiators and promoters of lung cancer.

J. Mulshine, M. Birrer, A. Treston, 1993, Chest.

Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.

T. Zhukov, M. Tockman, P. Taylor, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

The potential contributions of chronic inflammation to lung carcinogenesis.

J. Mulshine, S. Ballaz, 2003, Clinical lung cancer.

From clinical specimens to human cancer preclinical models—a journey the NCI‐cell line database—25 years later

J. Minna, J. Roth, I. Wistuba, 2019, Journal of cellular biochemistry.

MDR1 gene expression in lung cancer.

I. Pastan, M. Gottesman, A. Gazdar, 1989, Journal of the National Cancer Institute.

cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion

J. Mulshine, Y. Man, Yi Zhang, 2004, Breast Cancer Research and Treatment.

A Marker for Early Diagnosis of Lung Cancer

J. Mulshine, J. Tauler, Alfredo Martínez, 2004 .

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

S. Steinberg, J. Mulshine, M. Kelley, 1995, Journal of the National Cancer Institute.

Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.

J. Mulshine, A. Treston, I. Avis, 1999, Cancer research.

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth.

A. Malkinson, T. Moody, J. Mulshine, 1998, Experimental lung research.

Epithelial-directed drug delivery: influence of formulation and delivery devices.

J. Mulshine, L. Neckers, 2004, Lung cancer.

Lung cancer evolution to preinvasive management.

M. Tockman, J. Mulshine, L. D. De Luca, 2002, Clinics in chest medicine.

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

Matthijs Oudkerk, John K Field, David R Baldwin, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer

J. Mulshine, G. Chow, J. Tauler, 2010, Journal of biomedicine & biotechnology.

Clinical significance of the association of the Von Hippel-Lindau disease with pheochromocytoma and pancreatic apudoma.

J. Mulshine, R. Tubbs, R. Gifford, 1984, The American journal of the medical sciences.

Beyond transcriptional events

J. Mulshine, A. Treston, 1989, Nature.

Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.

M. Israel, A. Gazdar, J. Mulshine, 1988, Cancer research.

Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.

J. Mulshine, G. Pelosi, P. Solli, 2008, Lung cancer.

Lung cancer screening.

James L Mulshine, J. Mulshine, A. Ganti, 2005, The oncologist.

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis.

S. Steinberg, J. Minna, H. Pass, 1992, The Annals of thoracic surgery.

Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non‐small cell lung cancer and small cell lung cancer

S. Steinberg, J. Minna, A. Gazdar, 1996, Journal of cellular biochemistry. Supplement.

Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium.

S. Steinberg, J. Mulshine, S. Jensen, 1996, Lung cancer.

hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.

J. Mulshine, Huaitian Liu, J. Shih, 2010, Cancer research.

Cancer esearch cular and Cellular Pathobiology NP A 2 / B 1 Modulates Epithelial-Mesenchymal Transition R ung Cancer Cell

J. Mulshine, Huaitian Liu, J. Shih, 2010 .

Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia

S. Steinberg, S. Lippman, J. Mulshine, 2004, Clinical Cancer Research.

Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.

S. Steinberg, J. Mulshine, B. Johnson, 1993, Cancer research.

QIBA guidance: Computed tomography imaging for COVID-19 quantitative imaging applications

Raúl San José Estépar, D. Lynch, E. Hoffman, 2021, Clinical Imaging.

LIPOXYG ENASE INHIBITORS PREVENT LUNG CANCER GROWTH CARCINOGENESIS AND INHIBIT NON-SMALL CELL LUNG

A. Malkinson, T. Moody, J. Mulshine, 1998 .

Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.

S. Steinberg, J. Mulshine, M. Ebina, 1994, Cancer research.

Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer?

M. Tockman, J. Mulshine, 1997, Mayo Clinic proceedings.

Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells.

J. Mulshine, S. Hsu, P. Hsu, 1986, Journal of the National Cancer Institute.

Tobacco cessation and control a decade later: American society of clinical oncology policy statement update.

N. Hanna, J. Mulshine, Courtney A Tyne, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Status of lung cancer screening.

J. Mulshine, 2017, Journal of thoracic disease.

Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer

J. Mulshine, D. Allred, Jun Zhou, 2001, Breast Cancer Research and Treatment.

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

J. Mulshine, M. Kelley, I. Avis, 1997, Chest.

E-Cigarettes and Cancer Patients

K. Cummings, N. Hanna, N. Ikeda, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical Issues in the Management of Early Lung Cancer

James L Mulshine, J. Mulshine, 2005, Clinical Cancer Research.

lung cancer Lung cancer • 2: Screening and early diagnosis of

J. Mulshine, R. Smith, 2005 .

Issues in theManagement of Early Lung Cancer

J. Mulshine, 2005 .

Surgical considerations with lung cancer screening

J. Mulshine, Elizabeth E Warner, 2003, Journal of surgical oncology.

Lung cancer c 2: Screening and early diagnosis of lung cancer

J. Mulshine, R. Smith, 2002 .

Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study.

J. Mulshine, L. D. De Luca, G. Stoner, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability.

J. Mulshine, I. Avis, M. Miller, 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.

S. Larson, J. Mulshine, J. Carrasquillo, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Providing Guidance on Lung Cancer Screening to Patients and Physicians

J. Mulshine, A. McKee, N. Edelman, 2015 .

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.

T. Moody, J. Mulshine, M. Jett, 1996, The Journal of clinical investigation.

[Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo

T. Moody, J. Staley, J. Mulshine, 1991 .

Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection.

M. Tockman, J. Mulshine, E. Gold, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer and inflammation: interaction of chemokines and hnRNPs.

J. Mulshine, J. Tauler, 2009, Current opinion in pharmacology.

Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.

J. Mulshine, D. Venzon, Y. Man, 2000, American journal of respiratory cell and molecular biology.

A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.

J. Mulshine, J. Weisz, Q. Sang, 2005, Cancer detection and prevention.

Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation?

Z Chen, J. Mulshine, C. Van Waes, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Addressing tobacco use and cessation in cancer patients: Practices, perceptions, and barriers reported by oncology providers.

K. Cummings, N. Hanna, R. Herbst, 2013 .

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Heber MacMahon, John K Field, Shaf Keshavjee, 2012, The Journal of thoracic and cardiovascular surgery.

An actuarial approach to comparing early stage and late stage lung cancer mortality and survival.

J. Mulshine, B. Pyenson, Sara W Goldberg, 2010, Population health management.

Lung cancer screening: achieving more by intervening less.

C. Henschke, J. Mulshine, 2014, The Lancet. Oncology.

Reducing lung cancer risk: early detection.

J. Mulshine, 1999, Chest.

Not Significant But Important

J. Mulshine, F. Ondrey, 2013, Cancer Prevention Research.

Not Signi fi cant But Important

J. Mulshine, F. Ondrey, 2013 .

Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors.

J. Mulshine, L. D. De Luca, A. Dahl, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Moving to the routine management of pre symptomatic lung cancer.

M. Tockman, J. Mulshine, J. Tauler, 2001, Lung cancer.

Regional Delivery of Retinoids: A New Approach to Early Lung Cancer Intervention

J. Mulshine, R. Dedrick, L. M. Luca, 1998 .

Transferrin dependence of Ga(NO3)3 inhibition of growth in human‐derived small cell lung cancer cells

J. Mulshine, R. Neumann, R. Weiner, 1996, Journal of cellular biochemistry. Supplement.

Is the Gene Expression Pattern of Lung Cancer Detected by Screening With Spiral Computed Tomography Different from That of Symptom-Detected Lung Cancer?

J. Weinstein, J. Mulshine, 2004, Clinical Cancer Research.

Autocrine growth factors as therapeutic targets in lung cancer.

J. Mulshine, I. Avis, Y. Nakanishi, 1989, Chest.

The Long, Slow Road to Lung Cancer Cure.

J. Mulshine, B. Pyenson, 2021, JAMA oncology.

Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion

J. Mulshine, U. Pastorino, H. Prosch, 2019, ESMO Open.

Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health

G. Washko, S. Armato, M. Oudkerk, 2022, Annals of the American Thoracic Society.

Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer

J. Mulshine, J. Tauler, 2009, PPAR research.

Developing CT image-processing tools to accelerate progress in lung cancer drug development.

D. Yankelevitz, F. Hirsch, R. Avila, 2006, Oncology.

Monoclonal antibodies for early cytologic detection of lung cancer.

J. Mulshine, G. Shaw, 1993, Seminars in Thoracic and Cardiovascular Surgery.

Lung cancer screening: panacea or pipe dream?

J. Mulshine, A. Ganti, J. L. Mulshine, 2005, Annals of Oncology.

Early detection of lung cancer.

J. Mulshine, M. Birrer, E. Szabo, 1993, Seminars in oncology.

Effect of growth factors on the in vitro growth of small cell lung cancer as determined in a colorimetric assay

J. Minna, J. Mulshine, H. Kleinman, 1988 .

Epidemiology, prognostic factors, and prevention of lung cancer

J. Mulshine, E. Szabo, 1993, Current Opinion in Oncology.

Lung cancer screening with low-dose CT: more questions than answers--author's reply.

J. Mulshine, 2015, The Lancet Oncology.

Lung Cancer Workshop XI: Tobacco-Induced Disease Advances in Policy, Early Detection and Management

Raúl San José Estépar, D. Yankelevitz, J. Mulshine, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.

J. Austin, H. MacMahon, R. Munden, 2012, The Journal of thoracic and cardiovascular surgery.

Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.

M. Spitz, A. Flahault, I. Wistuba, 2002, International journal of oncology.

Monoclonal antibody alpha IR-3 inhibits non-small cell lung cancer growth in vitro and in vivo.

T. Moody, J. Mulshine, F. Cuttitta, 1996, Journal of cellular biochemistry. Supplement.

[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.

T. Moody, J. Staley, J. Mulshine, 1991, Cancer research.

Current issues in lung cancer screening.

J. Mulshine, 2005, Oncology.

Early Stage Lung Cancer—New Approaches to Evaluation and Treatment: Conference Summary Statement

C. Henschke, J. Jett, G. Scagliotti, 2005, Clinical Cancer Research.

Lung cancer screening moving forward.

J. Mulshine, W. Rzyman, 2016, Annals of translational medicine.

Prospects for lung-cancer screening

Claudia I Henschke, James L Mulshine, C. Henschke, 2000, The Lancet.

Control of tumor cell biology through regulation of peptide hormone processing.

J. Mulshine, F. Cuttitta, A. Treston, 1992, Journal of the National Cancer Institute. Monographs.

Screening for lung cancer.

J. Mulshine, R. Day, 2001, The New England journal of medicine.

Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets

Anatoly L. Mayburd, Anatoly L. Mayburd, Inna Golovchikova, 2008, Bioinform..

Issues with implementing a high‐quality lung cancer screening program

J. Mulshine, T. D’amico, James L. Mulshine, 2014, CA: a cancer journal for clinicians.

Molecular and Cellular Pathobiology Hnrnp A2/b1 Modulates Epithelial-mesenchymal Transition in Lung Cancer Cell Lines

J. Mulshine, Huaitian Liu, J. Shih, 2022 .

Radiologic Imaging of Lung Cancer

J. Mulshine, P. Shah, 2011 .

New developments in lung cancer screening.

J. Mulshine, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytometric validation of immunocytochemical observations in developing lung cancer

N. J. Pressman, M. Tockman, J. Mulshine, 1993, Diagnostic cytopathology.

Considerations in the development of lung cancer screening tools.

M. Tockman, J. Mulshine, C. Smart, 1989, Journal of the National Cancer Institute.

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.

S. Steinberg, J. Minna, A. Gazdar, 1993, Cancer research.

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation

P. V. van Ooijen, M. Oudkerk, S. Lam, 2020, JCO clinical cancer informatics.

Clinical practice. Lung cancer screening.

J. Mulshine, Daniel C Sullivan, 2005, The New England journal of medicine.

J. Austin, H. MacMahon, R. Munden, 2012, The Journal of thoracic and cardiovascular surgery.

Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules.

S. Armato, E. Kazerooni, M. McNitt-Gray, 2015, Journal of the American College of Radiology : JACR.

Evaluation of an interactive science publishing tool: toward enabling three-dimensional analysis of medical images.

Anthony P Reeves, Daniel Rinewalt, Betsy W Williams, 2015, Academic radiology.

Application of High-Resolution CT Imaging Data to Lung Cancer Drug Development: Measuring Progress Workshop IX

Raúl San José Estépar, D. Yankelevitz, J. Mulshine, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Application of High Resolution CT Imaging Data to Lung Cancer Drug Development: Measuring Progress

Raúl San José Estépar, D. Yankelevitz, J. Mulshine, 2011 .

An actuarial approach to comparing early stage and late stage lung cancer mortality and survival.

J. Mulshine, B. Pyenson, Sara W Goldberg, 2010, Population health management.

Commentary: lung cancer screening--progress or peril.

J. Mulshine, 2008, The oncologist.

Cell Lines Peripheral Airway Cell Differentiation in Human Lung Cancer

A. Gazdar, J. Mulshine, J. Whitsett, 2006 .

Tobacco cessation and control a decade later: American society of clinical oncology policy statement update.

N. Hanna, J. Mulshine, Courtney A Tyne, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of High-Resolution CT Imaging Data in Lung Cancer Drug Development : Measuring Progress April

J. Mulshine, 2017 .

Advancing patient-centric genomic medicine.

J. Mulshine, 2013, Oncology.

Need for uniformity in collection and reporting of data in cancer clinical trials.

J. Mulshine, R. Phelps, M. Dearing, 1990, Journal of the National Cancer Institute.

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.

Anatoly L. Mayburd, J. Mulshine, F. Ondrey, 2005, Cancer research.